CALR mutation was detected in 53% of subjects with ET and 56% of subjects with PMF, and 152 CALR mutations were identified clustering into 15 types, including deletions (n=8), insertions (n=3), and complex indels (n=4) [27]. This evidence concerns the gene CALR and essential thrombocythemia.